首页> 外文期刊>Antimicrobial agents and chemotherapy. >Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
【24h】

Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.

机译:拓扑异构酶IV重组基因对肺炎链球菌氟喹诺酮耐药菌株的适应性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The low prevalence of ciprofloxacin-resistant (Cp r) Streptococcus pneumoniae isolates carrying recombinant topoisomerase IV genes could be attributed to a fitness cost imposed by the horizontal transfer, which often implies the acquisition of larger-than-normal parE-parC intergenic regions. A study of the transcription of these genes and of the fitness cost for 24 isogenic Cp r strains was performed. Six first-level transformants were obtained either with PCR products containing the parC quinolone resistance-determining regions (QRDRs) of S. pneumoniae Cp r mutants with point mutations or with a PCR product that includes parE-QRDR-ant-parC-QRDR from a Cp r Streptococcus mitis isolate. The latter yielded two strains, T6 and T11, carrying parC-QRDR and parE-QRDR-ant-parC-QRDR, respectively. These first-level transformants were used as recipients in further transformations with the gyrA-QRDR PCR products to obtain 18 second-level transformants. In addition, strain Tr7 (which contains the GyrA E85K change) was used. Reverse transcription-PCR experiments showed that parE and parC were cotranscribed in R6, T6, and T11; and a single promoter located upstream of parE was identified in R6 by primer extension. The fitness of the transformants was estimated by pairwise competition with R6 in both one-cycle and two-cycle experiments. In the one-cycle experiments, most strains carrying the GyrA E85K change showed a fitness cost; the exception was recombinant T14. In the two-cycle experiments, a fitness cost was observed in most first-level transformants carrying the ParC changes S79F, S79Y, and D83Y and the GyrA E85K change; the exceptions were recombinants T6 and T11. The results suggest that there is no impediment due to a fitness cost for the spread of recombinant Cp r S. pneumoniae isolates, since some recombinants (T6, T11, and T14) exhibited an ability to compensate for the cost.
机译:携带重组拓扑异构酶IV基因的耐环丙沙星(Cp r)肺炎链球菌分离株患病率低可能归因于水平转移所带来的适应性成本,这通常意味着获得了比正常parE-parC多的基因间区域。对这些基因的转录和24种同基因Cp r菌株的适应性成本进行了研究。使用含有带有点突变的肺炎链球菌Cp r突变体的parC喹诺酮耐药性决定区(QRDR)的PCR产物或包含来自par。 Cp r微生物链球菌。后者产生两个菌株T6和T11,分别携带parC-QRDR和parE-QRDR-ant-parC-QRDR。这些第一级转化体被用作gyrA-QRDR PCR产物进一步转化中的受体,以获得18个第二级转化体。另外,使用了菌株Tr7(其包含GyrA E85K变化)。逆转录-PCR实验表明parE和parC在R6,T6和T11中共转录。通过引物延伸在R6中鉴定出位于parE上游的单个启动子。在一个周期和两个周期的实验中,通过与R6的成对竞争来评估转化体的适应性。在一个周期的实验中,大多数携带GyrA E85K改变的菌株均显示出适应性成本。例外是重组T14。在两个周期的实验中,在大多数具有ParC改变S79F,S79Y和D83Y以及GyrA E85K改变的一级转化子中观察到了适应性成本。重组体T6和T11除外。结果表明,由于一些重组体(T6,T11和T14)显示出补偿成本的能力,因此没有因重组肺炎链球菌肺炎链球菌分离株传播所需的费用而受到阻碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号